The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.EBI
University of Groningen
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.EBI
Sapienza University of Rome
Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.EBI
Purdue University
Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer.EBI
China Pharmaceutical University
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors.EBI
Chinese Academy of Sciences
Enzyme kinetics and inhibition of histone acetyltransferase KAT8.EBI
University of Groningen
Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.EBI
Chinese Academy of Sciences
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.EBI
Chinese Academy of Sciences
The relevance of KEBI
University of Groningen
Substituted heterocycles as aldehyde dehydrogenase inhibitorsBDB
Kayothera
Isoquinolin-3-yl carboxamides and preparation and use thereofBDB
Biosplice Therapeutics
Mu opioid receptor modulatorsBDB
University of California
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerBDB
The Institute of Cancer Research: Royal Cancer Hospital